Mechanism for the selection of anti-cancer networks by tumor-suppressive miRNAs
Project/Area Number |
23300359
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Tumor diagnosis
|
Research Institution | National Center of Neurology and Psychiatry |
Principal Investigator |
TSUCHIYA Naoto 独立行政法人国立がん研究センター, 研究所, ユニット長 (30322712)
|
Project Period (FY) |
2011-11-18 – 2014-03-31
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥9,360,000 (Direct Cost: ¥7,200,000、Indirect Cost: ¥2,160,000)
Fiscal Year 2013: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2012: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
|
Keywords | miRNA / マイクロRNA / がん抑制因子 / 発がん / 癌 / 細胞周期 / 発がんバリアー / 腫瘍学 / miRNA |
Research Abstract |
By detailed analysis of miR-101 and miR-22, we successfully found novel intra-cellular networks, which are deeply involved in the regulation of cancer cell proliferation. miR-101 was defined as a novel regulator for G2 checkpoint of cell cycle through the repression of several microtubule regulators, and resulted in its function as a inducer of p53-dependent apoptosis. We also confirmed that expression of miR-101 is frequently down-regulated in human cancers. We identified NEK9 as a crucial regulator for cell cycle progression in p53-inactivated cancer cells through the target screening of miR-22. Knockdown of NEK9 was caused to repress cell proliferation only in p53 mutant and deficient cells both in vitro and in vivo. NEK9 KD was indicated to induce prolonged inhibition of G1 to S progression of cell cycle leading to express senescence-like features of cancer cells. Our findings might provide a novel strategy for cancer therapy targeting mutant p53.
|
Report
(4 results)
Research Products
(54 results)
-
[Journal Article] Circulating Exosomal microRNAs as Biomarkers of Colon Cancer2014
Author(s)
Ogata-Kawata H, Izumiya M, Kurioka D, Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H, Watanabe M, Nakagama H, Yokota J, Kohno T, Tsuchiya N
-
Journal Title
Related Report
Peer Reviewed
-
[Journal Article] Circulating Exosomal microRNAs as Biomarkers of Colon Cancer2014
Author(s)
Ogata-Kawata H., Izumiya M., Kurioka D., Honnma Y., Yamada Y., Furuta K., Gunji T., Ohta H., Okamoto H., Sonoda H., Watanabe M., Nakagama H., Yokota J., Kohno T., Tsuchiya N.
-
Journal Title
Plos ONE
Volume: 9
Issue: 4
Pages: e92921-e92921
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
[Journal Article] Onset of quiescence following p53 mediated down-regulation of H2AX in normal cells2011
Author(s)
Atsumi Y, Fujimori H, Fukuda H, Inase A, Shinohe K, Yoshioka Y, Shikanai M, Ichijima Y, Unno J, Mizutani S, Tsuchiya N, Hippo Y, Nakagama H, Masutani M, Teraoka H, Yoshioka K
-
Journal Title
Related Report
Peer Reviewed
-
-
[Journal Article] Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p212011
Author(s)
Tsuchiya N, Izumiya M, Ogata-Kawata H, Okamoto K, Fujiwara Y, Nakai M, Okabe A, Schetter AJ, Bowman ED, Midorikawa Y, Sugiyama Y, Aburatani H, Harris CC, Nakagama H
-
Journal Title
Cancer Res
Volume: 71
Pages: 4628-39
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-